Secretary Robert F. Kennedy Jr. won’t acknowledge the scientific consensus that childhood vaccines do not cause autism. That ...
Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter ...
Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...
A Washington Post report on March 28 that the US Department of Health and Human Services (HHS) forced the Food and Drug ...
Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
Yes, there were some big hits like 'Reacher.' But pricey underperformers like 'Lord of the Rings' and 'Citadel' along with ...
Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...
On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...
Ousting of Oklahoma Forestry Services Director Goeller draws criticism from AG Drummond, acknowledging the heroism of ...